Cistero-50 Injection (Cisplatin Injection IP 50 mg)

Cistero-50 Injection is a branded oncology injectable formulation containing cisplatin, a platinum-based antineoplastic agent widely used in institutional and regulated pharmaceutical settings. Supplied under the Cisplatin Injection IP 50 mg specification, Cistero-50 Injection is manufactured for professional pharmaceutical distribution and export-oriented supply chains. AmeriDrugs provides this product exclusively to licensed importers, wholesalers, hospitals, pharmacies, and oncology-focused distributors across global markets.

Active Ingredient (API + Strength)

• Active Pharmaceutical Ingredient: Cisplatin IP

• Strength: 50 mg per 50 ml vial

• Pharmaceutical Form: Sterile solution for injection

Therapeutic Use (Informational, Non-Advisory)
Cistero-50 Injection contains cisplatin, which belongs to the class of platinum-containing chemotherapy agents. Cisplatin is utilized within established oncology treatment protocols for a variety of solid tumors in regulated healthcare environments. The therapeutic role of Cisplatin Injection IP 50 mg is determined by approved clinical guidelines and local regulatory authorities. This information is provided strictly for product identification and regulatory clarity and does not constitute medical advice.

Dosage Form & Route of Administration

• Dosage Form: Injectable solution

• Route of Administration: Intravenous infusion

• Prescription Status: Prescription-only medicine

• Intended for professional handling within regulated pharmaceutical channels

Quality & Manufacturing Standards
Cistero-50 Injection is produced in compliance with current Good Manufacturing Practices (GMP). Manufacturing processes are aligned with pharmacopeial standards to ensure product quality, sterility, and batch-to-batch consistency. Each batch undergoes quality control testing in accordance with applicable regulatory requirements for international pharmaceutical trade.

Packaging Information (Export-Oriented)

• Primary Pack: Glass vial containing 50 ml sterile solution

• Secondary Pack: Printed carton with compliant labeling

• Packaging suitable for international logistics and cold-chain supported distribution

• Export documentation and labeling customization available as per destination country requirements

Target Buyers

• Licensed pharmaceutical importers

• Oncology hospitals and specialty clinics

• Retail and wholesale pharmacies operating under prescription regulations

• Government and private healthcare procurement agencies

• International oncology-focused distributors

Regulatory & Compliance Note
Cistero-50 Injection is a prescription-only oncology product intended for regulated pharmaceutical distribution. Not for direct consumer self-use. Supply is subject to import authorization, local drug regulations, and institutional procurement policies in the destination market. AmeriDrugs adheres to global export compliance standards and supports documentation requirements for international buyers.